RELIEF THERAPEUTICS Holding SA. RELIEF THERAPEUTICS Holding SA, formerly known as mondoBIOTECH holding AG, is a Switzerland-based company that focuses on the development of treatments of diabetic complications and respiratory diseases. It specializes in clinical stage project and drugs of natural human origin (peptides and proteins) with a history of clinical testing and use in human patients. Its main products are Aviptadil and Atexakin Alfa. Aviptadil is an abundant biologically active endogenous human peptide acting as a ligand on specific G-protein coupled transmembrane receptors. Atexakin Alfa is a low-dosage formulation of interleukin-6 (IL-6), a cytokine that promotes nerve regeneration and remyelination, and protects neurons from toxic injuries.
Research Dynamics offers independent research with a focus on publicly-listed small- and mid-cap companies in Switzerland. Its global research team is comprised of experienced analysts based in our office in Zurich, and a team of around 30 highly qualified financial analysts and market researchers in India.
In addition, our research services include fundamental analyses, audits as well as media and social media monitoring, all delivered in a timely manner. Fundamental research is focused on valuation, financial modelling, company, market and peer group analyses.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.